Opioid signaling and design of analgesics
- 5 August 2022
- book chapter
- Published by Elsevier
- Vol. 195, 153-176
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (DA046487)
- University of Washington
This publication has 86 references indexed in Scilit:
- Efficacy and ligand bias at the μ‐opioid receptorBritish Journal of Pharmacology, 2013
- Functional Selectivity at the μ-Opioid Receptor: Implications for Understanding Opioid Analgesia and TolerancePharmacological Reviews, 2011
- Buprenorphine Metabolites, Buprenorphine-3-glucuronide and Norbuprenorphine-3-glucuronide, Are Biologically ActiveAnesthesiology, 2011
- Molecular Mechanisms of Opioid Receptor-dependent Signaling and BehaviorAnesthesiology, 2011
- Selective p38α MAPK Deletion in Serotonergic Neurons Produces Stress Resilience in Models of Depression and AddictionNeuron, 2011
- Crystal structure of the β2 adrenergic receptor–Gs protein complexNature, 2011
- The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestineJournal of Clinical Biochemistry and Nutrition, 2011
- μ-Opioid Receptors: Correlation of Agonist Efficacy for Signalling with Ability to Activate InternalizationMolecular Pharmacology, 2010
- Nociceptin/Orphanin FQ Receptor Activation Attenuates Antinociception Induced by Mixed Nociceptin/Orphanin FQ/μ-Opioid Receptor AgonistsThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomesLife Sciences, 1997